Don't initiate these calls if nifty traded below 4040
BUY ACC-787 @ 778 for a target 815+ stop loss 770
Buy Sesagoa-189 @ 180 for a target 190 stop loss 177
Buy Dr.Reddy-806 @ 800 for a target 816-821 stop loss 795
Buy Gujsidhche-16 for a target 21 stop loss 13 [positional]
stocks that are in news today:
Apotex questions Ranbaxy's ability to launch generic Aricept and Valtrex
Nestle, Takeda sue Lupin, Torrent over patent drug Oracea – BS
Ashok Leyland to seek shareholder nod to raise up to Rs 750 crore: NW18
Hindustan Zinc: petition filed in SC against stake sale by govt withdrawn – BS
Reliance Communication plea seeking clarification on TDSAT (Telecom Disputes Settlement And Appellate Tribunal) order dismissed: PTI
IOL Netcom board approves raising up to Rs 250 crore
Bajaj Hindusthan still in NSE F&O curb
Board meets: Aegis Logistics to consider buy back
34.4 crore Unitech shares to hit the market today ((QIP issue))
4.7 crore HCC shares to hit the market today ((QIP issue))
2.5 crore Sobha shares to hit the market today ((QIP issue))
NIFTY FUTURES LEVELS
RESISTANCE
4087
4125
4160
4243
4278
SUPPORT
4057
4043
4006
3971
Buy DR.REDDY'S,SUBEX AZURE
Strong & Weak futures
This is list of 10 strong futures
Colpal
DrReddy
BEML
ITC
Strtech
GTOffShore
ShreeCem
BPCL
Gail
Biocon
And this is list of 10 Weak futures
Aban
EssarOil
TCS
MoserBear
BomDyeing
Suzlon
AdlabsFilm
BhushanSteel
HDIL
Nifty is in Down Trend
NIFTY FUTURES (F & O):
Above 4087 level, expect short covering up to 4123-4125 zone and thereafter expect a jump up to 4158-4160 zone
by non-stop.
Support at 4057 level. Below this level, selling may continue up to 4043 level by non-stop.
Below 4006-4008 zone, expect panic up to 3971-3973 zone by non-stop.
On Positive Side, short rallies up to 4241-4243 zone can be used to sell. Stop Loss at 4276-4278 zone.
Short-Term Investors:
Bullish Trend. 3 closes above 4270 level, it can zoom up to 4830 level by non-stop.
Already SL triggered. 3 closes below 4270 level, it can tumble up to 3990 level by non-stop.
BSE SENSEX:
Higher opening expected. Profit booking should continue.
Short-Term Investors:
Short-Term trend is Bearish and target at around 12478 level on down side.
Maintain a Stop Loss at 14931 level for your short positions too.
Already SL triggered.
POSITIONAL BUY
Buy DR.REDDY'S LABS (NSE Cash)
Uptrend to continue.
Mild sell-off up to 802 level can be used to buy. If uptrend continues, then it may continue up to 819 level for time being.
If crosses & sustains at above 832 level then uptrend may continue.
Keep a Stop Loss at 789 level for your long positions too.
Buy SUBEX AZURE (NSE Cash)
Uptrend to continue.
Mild sell-off up to 77 level can be used to buy. If uptrend continues, then it may continue up to 80 level for time being.
If crosses & sustains at above 81 level then uptrend may continue.
Keep a Stop Loss at 75 level for your long positions too.
FII DATA
| FII trading activity on NSE and BSE in Capital Market Segment(In Rs. Crores) | ||||
| Category | Date | Buy Value | Sell Value | Net Value |
| FII | 08-Jul-2009 | 2002.64 | 2830.65 | -828.01 |
| DII trading activity on NSE and BSE in Capital Market Segment(In Rs. Crores) | ||||
| Category | Date | Buy Value | Sell Value | Net Value |
| DII | 08-Jul-2009 | 1983.81 | 1389.74 | +594.07 |
SPOT LEVELS TODAY
 | 4078.90 | ( -2.93 %) | -123.25 |  |
| 1 | 2 | 3 | ||
| Resistance | 4166.80 | 4254.70 | 4307.55 | |
| Support | 4026.05 | 3973.20 | 3885.30 | |
 | 13769.15 | ( -2.83 %) | -401.30 | | |
| 1 | 2 | 3 | |||
| Resistance | 13971.90 | 14174.65 | 14309.72 | ||
| Support | 13634.08 | 13499.01 | 13296.26 | ||
The Dow Jones Industrial Average closed at 8,178.41. Up by 14.81 points.
The Broader S&P 500 closed at 879.56. Down by 1.47 points.
The Nasdaq Composite Index closed at 1,747.17. Up by 1.00 points.
We did't get Rupee update.
Interesting findings on web:
Commerce and Industry minister Anand Sharma said the nation's exports shrank 29% in June from a year earlier, after a similar decline in May and a record 33% drop in April.
Interesting findings on web:
Commerce and Industry minister Anand Sharma said the nation's exports shrank 29% in June from a year earlier, after a similar decline in May and a record 33% drop in April.
The rupee weakened 0.9% to 48.89 a dollar at close in Mumbai, the lowest level since 15 May.
Blue chip stocks on Wall Street rallied in late trading ahead of a new earnings season and a further decline in crude-oil prices to a seven-week low.
Investors were encouraged by a detailed government plan to remove troubled assets from banks and a better-than-expected auction of 10-year Treasuries.
Stocks also rose after the International Monetary Fund said the world's economy was beginning to pull out of the worst recession in the post-World
War II era. The IMF predicted an expansion of 2.5% next year, better than the 1.9% projected in April.
Crude-oil futures tumbled more than 4% to a seven-week low, falling for the sixth straight session, as government data showed demand remained weak and inventories were rising.
Crude has now slumped 14% this month, as investors question whether supply-and-demand fundamentals are sufficient to justify oil's recent rally above $US70 a barrel.
Gold futures fell sharply in a continued reaction to the firming of the US dollar in recent weeks. Silver, platinum and palladium followed suit.
Retail stocks jumped ahead of Thursday's June same-store sales data.
Financials leading the list today with Bank of America (BAC) down $0.31. Most of the financials heading south.
And Google (GOOG) up nearly $6. Google preparing to roll out its own operating system targeting Microsoft.
The US dollar fell to the lowest level in almost five months against the Japanese yen as concerns about the global economy dented markets worldwide.
The dollar dropped more than 2% to ¥92.77. The yen has been the biggest beneficiary of the quest by investors to find the safest assets amid the economic and financial-market turmoil.
But the dollar was stronger against the other main currencies. The euro declined to $US1.3861 and the UK pound fell 0.5% to $US1.6052.
May consumer credit fell $3.22 billion versus a revised decline of $16.7 billion in the previous month. Economists surveyed by Briefing.com thought it would fall by $8.8 billion.
G8: The leaders of the world's eight foremost industrialized nations met in L'Aquila, Italy Wednesday to discuss the global economy, climate change and world security issues. In addition to President Obama, the leaders of Japan, Britain, France, Italy, Germany, Canada and Russia are also due to speak.
Stocks slipped through most of Wednesday as investors continued to worry about the economy and the quarterly reporting period in the aftermath of a big run up. But after touching fresh multi-month lows in the afternoon, stocks bounced back.
After the close, Dow component Alcoa (AA, Fortune 500) reported a quarterly loss of 26 cents per share as the global recession ate into the price and demand for its precious metals. But the decline was narrower than the loss of 38 cents per share analysts expected, according to Thomson Reuters. Alcoa earned 66 cents a year ago.
Alcoa shares gained 5% in after-hours trading.
But most quarterly reports aren't due until later this month and the results are expected to be fairly grim. Profits for S&P 500 companies are expected to have fallen 36% from a year ago, according to the latest Thomson Reuters estimates.
Japan's Nikkei average fell 0.5 percent on Thursday, with exporters such as Canon Inc (7751.T) retreating as the yen surged to 5-month highs against the dollar the previous day on growing concerns about the health of the global economy.
The Nikkei's decline was cushioned, however, after U.S. aluminium giant Alcoa Inc (AA.N) reported a smaller-than-expected loss after the market close on Wednesday, giving a positive tone to the start of the closely-watched U.S. earnings season.
The benchmark Nikkei .N225 fell 49.67 points to 9,371.08. In early trade the index hit 9,307.81, its lowest level since late May, before paring some losses as the dollar rebounded above 93 yen on Thursday after sliding to a five-month low of around 91.8 yen the previous day.
The Japanese yen rose to its highest level in several months against other currencies Wednesday as traders retreated from riskier, higher-yielding investments ahead of the U.S. earnings season, which began late Wednesday with Alcoa ( AA - news - people ) reported a quarterly loss. The yen gained on the Australian and New Zealand dollars and reached its highest level against the greenbacksince February. Some experts speculate that the Japanese government may intervene to weaken the yen in order to boost its giant export sector.
Hong Kong stocks dropped Thursday, unable to sustain early gains as banking stocks led by market heavyweight HSBC Holdings posted declines. The Hang Seng Index fell 0.5% to 17,638.34, after opening higher, to stretch losses into a fourth straight session. The Hang Seng China Enterprises Index, also known as the H-share index, gave up 0.7% to 10,497.61. Shares of Chinese banks fell on concerns strong lending data for June could result in tightened monetary policy controls.
Hong Kong stocks dropped, dragging the Hang Seng Index to a two-week low, as lower oil and metal prices dragged commodity stocks lower. Property and banking shares declined on concern the government will restrict lending for real estate investment.
DELIVERY BUY
DELIVERY BUY
Pharma: CRAM Players Get A Fresh Lease Of Life
Aurobindo, Dr. Reddy's, Jubilant, Lupin, Dishman and Shasun could be key beneficiaries of renewed interest in Indian CRAM players from MNC Pharma
Aurobindo, Dr. Reddy's, Jubilant, Lupin, Dishman and Shasun could be key beneficiaries of renewed interest in Indian CRAM players from MNC Pharma
After Pfizer announced a deal with Aurobindo Pharma to pick up 15 generic drugs from the latter to be marketed in the US, it is the turn of Pharmaceutical company GlaxoSmithKline PLC to reach a deal with Indian drug developer Dr. Reddy's Laboratories Ltd. to develop and market selected products across many emerging markets.
London-based Glaxo did not reveal terms of the deal, which is effective immediately but excludes India. Under the agreement, Glaxo will gain exclusive access to Dr. Reddy's portfolio and future pipeline of more than 100 branded pharmaceuticals in fast growing therapeutic segments such as cardiovascular, diabetes, oncology, gastroenterology and pain management.
The products will be manufactured by Dr. Reddy's and licensed and supplied by Glaxo in various countries in Africa, the Middle East, Asia Pacific and Latin America. In some markets, products will be co-marketed by Glaxo and Dr. Reddy's. Revenues will be reported by Glaxo, and shared with Dr. Reddy's, Glaxo said.
"This is another significant step forward in our strategy to grow and diversify GSK's business in emerging markets," said Abbas Hussain, president for emerging markets at GlaxoSmithKline. "Growth in both population and economic prosperity is leading to increased demand for branded pharmaceuticals.
(Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.)
--
Arvind Parekh
+ 91 98432 32381
